Ardelyx, Inc. ( ARDX) - Key Metrics
ARDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.49 | -$0.07 | -$0.03 | -$0.03 |
| 2026Q1 | $0.38 | -$0.15 | -$0.13 | -$0.13 |
| 2025Q4 | $0.51 | $0 | $0.09 | $0.08 |
| 2025Q3 | $0.46 | $0 | $0 | $0 |
| 2025Q2 | $0.41 | -$0.08 | -$0.11 | -$0.11 |
ARDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -18.21 |
| 2026Q1 | 0% | -9.98 |
| 2025Q4 | 0% | -857.35 |
| 2025Q3 | 0% | -344.38 |
| 2025Q2 | 0% | -12.33 |
ARDX
Price: $4.06
52 week price:
Earnings Per Share: -0.23 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8.1 million
Ebitda: -20.5 millionMarket Capitalization: 1.0 billion